Congratulations to Professor Selma Masri and PhD student Bridget Fortin, who recently published a study in Nature Immunology showing that the circadian clock – the biological pacemaker that governs daily rhythms in physiological processes, including immune functions – can be leveraged to enhance the efficacy of checkpoint therapy in colon cancer. The study provides deeper insights into the intricate relationship among the circadian clock, immune regulation and tumor development. It also found that a therapeutic approach optimizing time-of-day delivery based on an individual’s unique circadian patterns offers new avenues for prevention and treatment.
Link to Story: Click Here